Ilex Guayusa
OTHER NAME(S): Guayusa, Runa Tea, Wayusa, Ilex guayusa
Overview
Ilex guayusa is a tree native to South America. Its leaves are consumed as a beverage in rituals. It's also used in traditional medicine.
Ilex guayusa contains caffeine. It also contains chemicals that might have antioxidant and antibacterial effects.
People sometimes use Ilex guayusa for memory and thinking skills, diabetes, and many other conditions, but there is no good scientific evidence to support these uses.
Don't confuse Ilex guayusa with caffeine or other caffeine-containing ingredients, including black tea, green tea, oolong tea, coffee, coffee charcoal, green coffee, cola nut, guarana, or yerba mate. These are not the same.
Uses
We currently have no information for Ilex guayusa overview.
Precautions
When taken by mouth: Ilex guayusa is commonly consumed as a beverage. But there isn't enough reliable information to know if Ilex guayusa is safe when used in larger amounts as medicine. Ilex guayusa also contains caffeine, which may cause side effects at high doses.
Pregnancy and breast-feeding: There isn't enough reliable information to know if Ilex guayusa is safe to use when pregnant or breast-feeding. Stay on the safe side and avoid use.
Anxiety disorders: The caffeine in Ilex guayusa might make anxiety worse.
Bleeding disorders: The caffeine in Ilex guayusa might slow blood clotting and make bleeding disorders worse.
Heart disease: The caffeine in Ilex guayusa might cause irregular heartbeat in certain people. Use with caution.
Diabetes: The caffeine in Ilex guayusa might affect blood sugar. Use Ilex guayusa with caution if you have diabetes.
Diarrhea: The caffeine in Ilex guayusa, especially when taken in large amounts, can worsen diarrhea.
Seizures: Ilex guayusa contains caffeine. People with epilepsy should avoid using caffeine in high doses. Low doses of caffeine should be used cautiously.
Glaucoma: The caffeine in Ilex guayusa increases the pressure inside the eye. The increase occurs within 30 minutes and lasts for at least 90 minutes after consuming caffeine.
High blood pressure: The caffeine in Ilex guayusa might increase blood pressure in people with high blood pressure. But this doesn't seem to occur in people who consume caffeine regularly.
Loss of bladder control: Ilex guayusa contains caffeine. Caffeine can make bladder control worse by increasing the need and the urge to urinate.
Irritable bowel syndrome (IBS): Ilex guayusa contains caffeine. The caffeine in Ilex guayusa, especially when taken in large amounts, may worsen diarrhea and other symptoms of IBS.
Thinning bones (Osteoporosis): The caffeine in Ilex guayusa can flush calcium out of the body through the kidneys. This calcium loss might weaken bones. If you have osteoporosis, don't consume more than 300 mg of caffeine daily. But if you are generally healthy and getting enough calcium from your food or supplements, taking up to 400 mg of caffeine daily doesn't seem to increase the risk of getting osteoporosis.
Interactions
Moderate Interaction
Be cautious with this combination
- Adenosine (Adenocard) interacts with Ilex guayusaThe caffeine in Ilex guayusa might block the effects of adenosine, which is used to do a test called a cardiac stress test. Stop consuming Ilex guayusa or other caffeine-containing products at least 24 hours before a cardiac stress test.
- Clozapine (Clozaril) interacts with Ilex guayusaThe body breaks down clozapine to get rid of it. The caffeine in Ilex guayusa might decrease how fast the body breaks down clozapine. Taking Ilex guayusa along with clozapine can increase the effects and side effects of clozapine.
- Dipyridamole (Persantine) interacts with Ilex guayusaThe caffeine in Ilex guayusa might block the effects of dipyridamole. Dipyridamole is often used by doctors to do a test on the heart called a cardiac stress test. Stop taking Ilex guayusa or other caffeine-containing products at least 24 hours before a cardiac stress test.
- Ephedrine interacts with Ilex guayusaStimulant drugs speed up the nervous system. Caffeine, which is found in Ilex guayusa, and ephedrine are both stimulant drugs. Taking Ilex guayusa and ephedrine might cause too much stimulation and sometimes serious side effects and heart problems. Do not take caffeine-containing products and ephedrine at the same time.
- Flutamide (Eulexin) interacts with Ilex guayusaThe body breaks down flutamide to get rid of it. Caffeine in Ilex guayusa might decrease how quickly the body breaks down flutamide. Taking Ilex guayusa along with flutamide might increase the effects and side effects of flutamide.
- Lithium interacts with Ilex guayusaThe body naturally gets rid of lithium. The caffeine in Ilex guayusa can increase how quickly the body gets rid of lithium. If you take products that contain caffeine and you take lithium, don't change your dose of caffeine quickly. Stopping caffeine too quickly can increase the side effects of lithium. If you stop using caffeine, reduce the dose slowly.
- Medications for depression (MAOIs) interacts with Ilex guayusaIlex guayusa contains caffeine. There is some concern that caffeine can interact with certain medications, called MAOIs. If caffeine is taken with these medications, it might increase the risk for serious side effects including fast heartbeat and very high blood pressure. Some common MAOIs include phenelzine (Nardil), selegiline (Zelapar), and tranylcypromine (Parnate).
- Medications that slow blood clotting (Anticoagulant / Antiplatelet drugs) interacts with Ilex guayusaIlex guayusa might slow blood clotting. Taking Ilex guayusa along with medications that also slow blood clotting might increase the risk of bruising and bleeding.
- Medications for diabetes (Antidiabetes drugs) interacts with Ilex guayusaIlex guayusa might lower blood sugar levels. Taking Ilex guayusa along with diabetes medications might cause blood sugar to drop too low. Monitor your blood sugar closely.
- Nicotine interacts with Ilex guayusaIlex guayusa contains caffeine. Taking coffee along with nicotine might cause a fast heartbeat and increase blood pressure.
- Pentobarbital (Nembutal) interacts with Ilex guayusaIlex guayusa contains caffeine. The stimulant effects of caffeine can block the sleep-producing effects of pentobarbital.
- Phenobarbital (Luminal) interacts with Ilex guayusaPhenobarbital is used to treat seizures. Caffeine, in Ilex guayusa might reduce the effects of phenobarbital. Taking Ilex guayusa with phenobarbital might reduce its effects and increase the risk of seizures.
- Phenylpropanolamine interacts with Ilex guayusaThe caffeine in Ilex guayusa can stimulate the body. Phenylpropanolamine can also stimulate the body. Taking Ilex guayusa along with phenylpropanolamine might cause too much stimulation and increase heartbeat, blood pressure, and cause nervousness.
- Phenytoin (Dilantin) interacts with Ilex guayusaPhenytoin is used to control some types of seizures. Caffeine in Ilex guayusa might reduce the effects of phenytoin. Taking Ilex guayusa with phenytoin might reduce its effects and increase the risk of seizures.
- Pioglitazone (Actos) interacts with Ilex guayusaThe caffeine in Ilex guayusa might increase the amount of pioglitazone that the body absorbs. Taking Ilex guayusa might increase the effects and adverse effects of pioglitazone.
- Riluzole (Rilutek) interacts with Ilex guayusaThe body breaks down riluzole to get rid of it. Taking Ilex guayusa can decrease how fast the body breaks down riluzole and increase the effects and side effects of riluzole.
- Stimulant drugs interacts with Ilex guayusaStimulants, such as amphetamines and cocaine, speed up the nervous system. By speeding up the nervous system, stimulant medications can increase blood pressure and speed up the heartbeat. Caffeine in Ilex guayusa can also speed up the nervous system. Taking Ilex guayusa along with stimulant drugs might cause serious problems including increased heart rate and high blood pressure.
- Valproate interacts with Ilex guayusaValproate is used to treat seizures. Caffeine in Ilex guayusa might reduce the effects of valproate. Taking Ilex guayusa with valproate might reduce its effects and increase the risk of seizures.
- Verapamil (Calan, others) interacts with Ilex guayusaThe body breaks down the caffeine in Ilex guayusa to get rid of it. Verapamil can decrease how quickly the body gets rid of caffeine. Taking Ilex guayusa along with verapamil can increase the risk of caffeine side effects including jitteriness, headache, and fast heartbeat.
- Water pills (Diuretic drugs) interacts with Ilex guayusaIlex guayusa contains caffeine. Caffeine, especially in large amounts, can reduce potassium levels in the body. "Water pills" can also decrease potassium levels in the body. Taking large amounts of caffeine along with "water pills" might decrease potassium levels too much.
Minor Interaction
Be watchful with this combination
- Alcohol (Ethanol) interacts with Ilex guayusaThe body breaks down the caffeine in Ilex guayusa to get rid of it. Alcohol can decrease how quickly the body breaks down caffeine. Taking Ilex guayusa along with alcohol might increase the risk of caffeine side effects including jitteriness, headache, and fast heartbeat.
- Antibiotics (Quinolone antibiotics) interacts with Ilex guayusaThe body breaks down caffeine from Ilex guayusa to get rid of it. Some drugs can decrease how quickly the body breaks down caffeine. Taking these drugs along with Ilex guayusa might increase the risk of caffeine side effects including jitteriness, headache, and fast heartbeat.
- Birth control pills (Contraceptive drugs) interacts with Ilex guayusaIlex guayusa contains caffeine. The body breaks down caffeine to get rid of it. Birth control pills can decrease how quickly the body breaks down caffeine. This might increase the risk for side effects from caffeine, such as jitteriness, headache, and fast heartbeat.
- Cimetidine (Tagamet) interacts with Ilex guayusaThe body breaks down the caffeine in Ilex guayusa to get rid of it. Cimetidine can decrease how quickly the body breaks down caffeine. Taking cimetidine along with Ilex guayusa might increase the chance of caffeine side effects including jitteriness, headache, and fast heartbeat.
- Disulfiram (Antabuse) interacts with Ilex guayusaThe body breaks down the caffeine in Ilex guayusa to get rid of it. Disulfiram can decrease how quickly the body gets rid of caffeine. Taking Ilex guayusa along with disulfiram might increase the risk of caffeine side effects, including jitteriness, irritability, and fast heartbeat.
- Estrogens interacts with Ilex guayusaThe body breaks down caffeine to get rid of it. Estrogens can decrease how quickly the body breaks down caffeine. Taking estrogen along with Ilex guayusa can increase the risk of side effects such as jitteriness, headache, and fast heartbeat.
- Fluconazole (Diflucan) interacts with Ilex guayusaThe body breaks down the caffeine in Ilex guayusa to get rid of it. Fluconazole might decrease how quickly the body gets rid of caffeine. Taking fluconazole and Ilex guayusa might increase the risk of caffeine side effects, including jitteriness and fast heartbeat.
- Fluvoxamine (Luvox) interacts with Ilex guayusaThe body breaks down the caffeine in Ilex guayusa to get rid of it. Fluvoxamine can decrease how quickly the body breaks down caffeine. Taking caffeine along with fluvoxamine might increase the risk of caffeine side effects.
- Metformin (Glucophage) interacts with Ilex guayusaIlex guayusa contains caffeine. The body breaks down caffeine to get rid of it. Metformin can decrease how quickly the body breaks down caffeine. Taking metformin along with Ilex guayusa might increase the risk of caffeine side effects. such as jitteriness, headache, and fast heartbeat.
- Methoxsalen (Oxsoralen) interacts with Ilex guayusaIlex guayusa contains caffeine. The body breaks down caffeine to get rid of it. Methoxsalen can decrease how quickly the body breaks down caffeine. Taking methoxsalen along with Ilex guayusa might increase the risk of caffeine side effects, such as jitteriness, headache, and fast heartbeat.
- Mexiletine (Mexitil) interacts with Ilex guayusaIlex guayusa contains caffeine. The body breaks down caffeine to get rid of it. Mexiletine can decrease how quickly the body breaks down caffeine. Taking mexiletine along with Ilex guayusa might increase the risk of caffeine side effects, such as jitteriness, headache, and fast heartbeat.
- Medications for asthma (Beta-adrenergic agonists) interacts with Ilex guayusaIlex guayusa contains caffeine. Caffeine can stimulate the heart. Some medications for asthma can also stimulate the heart. Taking caffeine with some medications for asthma might cause too much stimulation and cause heart problems.
- Phenothiazines interacts with Ilex guayusaIlex guayusa contains caffeine. The body breaks down caffeine to get rid of it. Phenothiazines can decrease how quickly the body breaks down caffeine. Taking phenothiazines along with Ilex guayusa might increase the risk of caffeine side effects, such as jitteriness, headache, and fast heartbeat.
- Terbinafine (Lamisil) interacts with Ilex guayusaIlex guayusa contains caffeine. The body breaks down caffeine to get rid of it. Terbinafine can decrease how fast the body gets rid of caffeine and increase the risk of caffeine side effects such as jitteriness, headache, and fast heartbeat.
- Theophylline interacts with Ilex guayusaIlex guayusa contains caffeine. Caffeine works similarly to theophylline. Caffeine can also decrease how quickly the body gets rid of theophylline. Taking Ilex guayusa along with theophylline might increase the effects and side effects of theophylline.
- Tiagabine (Gabitril) interacts with Ilex guayusaIlex guayusa contains caffeine. Tiagabine is used to treat seizures. There is some concern that caffeine can reduce the effects of tiagabine. But studies show that tiagabine still works even when taken with caffeine.
- Ticlopidine (Ticlid) interacts with Ilex guayusaIlex guayusa contains caffeine. The body breaks down caffeine to get rid of it. Ticlopidine can decrease how fast the body gets rid of caffeine. Taking Ilex guayusa along with ticlopidine might increase the risk of caffeine side effects, such as jitteriness, headache, and fast heartbeat.
Dosing
There isn't enough reliable information to know what an appropriate dose of Ilex guayusa might be. Keep in mind that natural products are not always necessarily safe and dosages can be important. Be sure to follow relevant directions on product labels and consult a healthcare professional before using.
References
- McEvoy GK, ed. AHFS Drug Information. Bethesda, MD: American Society of Health-System Pharmacists, 1998.
- Harder S, Fuhr U, Staib AH, Wolff T. Ciprofloxacin-caffeine: a drug interaction established using in vivo and in vitro investigations. Am J Med 1989;87:89S-91S.
- Carbo M, Segura J, De la Torre R, et al. Effect of quinolones on caffeine disposition. Clin Pharmacol Ther 1989;45:234-40.
- Healy DP, Polk RE, Kanawati L, et al. Interaction between oral ciprofloxacin and caffeine in normal volunteers. Antimicrob Agents Chemother 1989;33:474-8.
- Mester R, Toren P, Mizrachi I, et al. Caffeine withdrawal increases lithium blood levels. Biol Psychiatry 1995;37:348-50.
- Jefferson JW. Lithium tremor and caffeine intake: two cases of drinking less and shaking more. J Clin Psychiatry 1988;49:72-3.
- Joeres R, Klinker H, Heusler H, et al. Influence of mexiletine on caffeine elimination. Pharmacol Ther 1987;33:163-9.
- Vahedi K, Domingo V, Amarenco P, Bousser MG. Ischemic stroke in a sportsman who consumed MaHuang extract and creatine monohydrate for bodybuilding. J Neurol Neurosurg Psychiatr 2000;68:112-3.
- Wakabayashi K, Kono S, Shinchi K, et al. Habitual coffee consumption and blood pressure: A study of self-defense officials in Japan. Eur J Epidemiol 1998;14:669-73.
- Hodgson JM, Puddey IB, Burke V, et al. Effects on blood pressure of drinking green and black tea. J Hypertens 1999;17:457-63.
- Wallach J. Interpretation of Diagnostic Tests. A synopsis of Laboratory Medicine. Fifth ed; Boston, MA: Little Brown, 1992.
- Chiu KM. Efficacy of calcium supplements on bone mass in postmenopausal women. J Gerontol A Biol Sci Med Sci 1999;54:M275-80.
- Rapuri PB, Gallagher JC, Kinyamu HK, Ryschon KL. Caffeine intake increases the rate of bone loss in elderly women and interacts with vitamin D receptor genotypes. Am J Clin Nutr 2001;74:694-700.
- Pollock BG, Wylie M, Stack JA, et al. Inhibition of caffeine metabolism by estrogen replacement therapy in postmenopausal women. J Clin Pharmacol 1999;39:936-40.
- Nurminen ML, Niittynen L, Korpela R, Vapaatalo H. Coffee, caffeine and blood pressure: a critical review. Eur J Clin Nutr 1999;53:831-9.
- Dews PB, Curtis GL, Hanford KJ, O'Brien CP. The frequency of caffeine withdrawal in a population-based survey and in a controlled, blinded pilot experiment. J Clin Pharmacol 1999;39:1221-32.
- Boozer CN, Nasser JA, Heymsfield SB, et al. An herbal supplement containing Ma Huang-Guarana for weight loss: a randomized, double-blind trial. Int J Obes Relat Metab Disord 2001;25:316-24.
- Electronic Code of Federal Regulations. Title 21. Part 182 -- Substances Generally Recognized As Safe. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=182
- Hagg S, Spigset O, Mjorndal T, Dahlqvist R. Effect of caffeine on clozapine pharmacokinetics in healthy volunteers. Br J Clin Pharmacol 2000;49:59-63.
- Watson JM, Jenkins EJ, Hamilton P, et al. Influence of caffeine on the frequency and perception of hypoglycemia in free-living patients with type 1 diabetes. Diabetes Care 2000;23:455-9.
- Lloyd T, Johnson-Rollings N, Eggli DF, et al. Bone status among postmenopausal women with different habitual caffeine intakes: a longitudinal investigation. J Am Coll Nutr 2000;19:256-61.
- Sinclair CJ, Geiger JD. Caffeine use in sports. A pharmacological review. J Sports Med Phys Fitness 2000;40:71-9.
- Haller CA, Benowitz NL. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. N Engl J Med 2000;343:1833-8.
- Ali M, Afzal M. A potent inhibitor of thrombin stimulated platelet thromboxane formation from unprocessed tea. Prostaglandins Leukot Med 1987;27:9-13.
- Ardlie NG, Glew G, Schultz BG, Schwartz CJ. Inhibition and reversal of platelet aggregation by methyl xanthines. Thromb Diath Haemorrh 1967;18:670-3.
- Samarrae WA, Truswell AS. Short-term effect of coffee on blood fibrinolytic activity in healthy adults. Atherosclerosis 1977;26:255-60.
- Klag MJ, Wang NY, Meoni LA, et al. Coffee intake and risk of hypertension: The John Hopkins precursors study. Arch Intern Med 2002;162:657-62.
- Ferrini RL, Barrett-Connor E. Caffeine intake and endogenous sex steroid levels in postmenopausal women. The Rancho Bernardo Study. Am J Epidemiol 1996:144:642-4.
- Avisar R, Avisar E, Weinberger D. Effect of coffee consumption on intraocular pressure. Ann Pharmacother 2002;36:992-5..
- Bell DG, Jacobs I, Ellerington K. Effect of caffeine and ephedrine ingestion on anaerobic exercise performance. Med Sci Sports Exerc 2001;33:1399-403.
- Horner NK, Lampe JW. Potential mechanisms of diet therapy for fibrocystic breast conditions show inadequate evidence of effectiveness. J Am Diet Assoc 2000;100:1368-80.
- Bara AI, Barley EA. Caffeine for asthma. Cochrane Database Syst Rev 2001;4:CD001112..
- Shekelle PG, Hardy ML, Morton SC, et al. Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: a meta-analysis. JAMA 2003;289:1537-45..
- Massey LK. Is caffeine a risk factor for bone loss in the elderly? Am J Clin Nutr 2001;74:569-70.
- Kockler DR, McCarthy MW, Lawson CL. Seizure activity and unresponsiveness after hydroxycut ingestion. Pharmacotherapy 2001;21:647-51..
- Nix D, Zelenitsky S, Symonds W, et al. The effect of fluconazole on the pharmacokinetics of caffeine in young and elderly subjects. Clin Pharmacol Ther 1992;51:183.
- Massey LK, Whiting SJ. Caffeine, urinary calcium, calcium metabolism and bone. J Nutr 1993;123:1611-4.
- Nawrot P, Jordan S, Eastwood J, et al. Effects of caffeine on human health. Food Addit Contam 2003;20:1-30.
- May DC, Jarboe CH, VanBakel AB, Williams WM. Effects of cimetidine on caffeine disposition in smokers and nonsmokers. Clin Pharmacol Ther 1982;31:656-61.
- Abernethy DR, Todd EL. Impairment of caffeine clearance by chronic use of low-dose oestrogen-containing oral contraceptives. Eur J Clin Pharmacol 1985;28:425-8.
- Brown NJ, Ryder D, Branch RA. A pharmacodynamic interaction between caffeine and phenylpropanolamine. Clin Pharmacol Ther 1991;50:363-71.
- Sanderink GJ, Bournique B, Stevens J, et al. Involvement of human CYP1A isoenzymes in the metabolism and drug interactions of riluzole in vitro. Pharmacol Exp Ther 1997;282:1465-72.
- Wahllander A, Paumgartner G. Effect of ketoconazole and terbinafine on the pharmacokinetics of caffeine in healthy volunteers. Eur J Clin Pharmacol 1989;37:279-83.
- Carrillo JA, Benitez J. Clinically significant pharmacokinetic interactions between dietary caffeine and medications. Clin Pharmacokinet 2000;39:127-53.
- Stanek EJ, Melko GP, Charland SL. Xanthine interference with dipyridamole-thallium-201 myocardial imaging. Pharmacother 1995;29:425-7.
- Smith A. Effects of caffeine on human behavior. Food Chem Toxicol 2002;40:1243-55.
- Underwood DA. Which medications should be held before a pharmacologic or exercise stress test? Cleve Clin J Med 2002;69:449-50.
- Aqel RA, Zoghbi GJ, Trimm JR, et al. Effect of caffeine administered intravenously on intracoronary-administered adenosine-induced coronary hemodynamics in patients with coronary artery disease. Am J Cardiol 2004;93:343-6.
- Zheng XM, Williams RC. Serum caffeine levels after 24-hour abstention: clinical implications on dipyridamole (201)Tl myocardial perfusion imaging. J Nucl Med Technol 2002;30:123-7.
- Institute of Medicine. Caffeine for the Sustainment of Mental Task Performance: Formulations for Military Operations. Washington, DC: National Academy Press, 2001. Available at: https://books.nap.edu/books/0309082587/html/index.html.
- Holmgren P, Norden-Pettersson L, Ahlner J. Caffeine fatalities--four case reports. Forensic Sci Int 2004;139:71-3.
- Dews PB, O'Brien CP, Bergman J. Caffeine: behavioral effects of withdrawal and related issues. Food Chem Toxicol 2002;40:1257-61.
- Beach CA, Mays DC, Guiler RC, et al. Inhibition of elimination of caffeine by disulfiram in normal subjects and recovering alcoholics. Clin Pharmacol Ther 1986;39:265-70.
- Durrant KL. Known and hidden sources of caffeine in drug, food, and natural products. J Am Pharm Assoc 2002;42:625-37.
- Cannon ME, Cooke CT, McCarthy JS. Caffeine-induced cardiac arrhythmia: an unrecognised danger of healthfood products. Med J Aust 2001;174:520-1.
- Lane JD, Barkauskas CE, Surwit RS, Feinglos MN. Caffeine impairs glucose metabolism in type 2 diabetes. Diabetes Care 2004;27:2047-8.
- Petrie HJ, Chown SE, Belfie LM, et al. Caffeine ingestion increases the insulin response to an oral-glucose-tolerance test in obese men before and after weight loss. Am J Clin Nutr 2004;80:22-8.
- Haller CA, Benowitz NL, Jacob P 3rd. Hemodynamic effects of ephedra-free weight-loss supplements in humans. Am J Med 2005;118:998-1003..
- Benowitz NL, Osterloh J, Goldschlager N, et al. Massive catecholamine release from caffeine poisoning. JAMA 1982;248:1097-8.
- Leson CL, McGuigan MA, Bryson SM. Caffeine overdose in an adolescent male. J Toxicol Clin Toxicol 1988;26:407-15.
- Anderson BJ, Gunn TR, Holford NH, Johnson R. Caffeine overdose in a premature infant: clinical course and pharmacokinetics. Anaesth Intensive Care 1999;27:307-11.
- Juliano LM, Griffiths RR. A critical review of caffeine withdrawal: empirical validation of symptoms and signs, incidence, severity, and associated features. Psychopharmacology (Berl) 2004;176:1-29.
- Winkelmayer WC, Stampfer MJ, Willett WC, Curhan GC. Habitual caffeine intake and the risk of hypertension in women. JAMA 2005;294:2330-5.
- Watson JM, Sherwin RS, Deary IJ, et al. Dissociation of augmented physiological, hormonal and cognitive responses to hypoglycaemia with sustained caffeine use. Clin Sci (Lond) 2003;104:447-54.
- Raaska K, Raitasuo V, Laitila J, Neuvonen PJ. Effect of caffeine-containing versus decaffeinated coffee on serum clozapine concentrations in hospitalised patients. Basic Clin Pharmacol Toxicol 2004;94:13-8.
- Forrest WH Jr, Bellville JW, Brown BW Jr. The interaction of caffeine with pentobarbital as a nighttime hypnotic. Anesthesiology 1972;36:37-41.
- Lake CR, Rosenberg DB, Gallant S, et al. Phenylpropanolamine increases plasma caffeine levels. Clin Pharmacol Ther 1990;47:675-85.
- Seifert, J. G., Nelson, A., Devonish, J., Burke, E. R., and Stohs, S. J. Effect of acute administration of an herbal preparation on blood pressure and heart rate in humans. Int.J.Med.Sci. 2011;8(3):192-197.
- Kynast-Gales SA, Massey LK. Effect of caffeine on circadian excretion of urinary calcium and magnesium. J Am Coll Nutr. 1994;13:467-72.
- Shet, M. S., McPhaul, M., Fisher, C. W., Stallings, N. R., and Estabrook, R. W. Metabolism of the antiandrogenic drug (Flutamide) by human CYP1A2. Drug Metab Dispos. 1997;25(11):1298-1303.
- Staib, A. H., Stille, W., Dietlein, G., Shah, P. M., Harder, S., Mieke, S., and Beer, C. Interaction between quinolones and caffeine. Drugs 1987;34 Suppl 1:170-174.
- Stille, W., Harder, S., Mieke, S., Beer, C., Shah, P. M., Frech, K., and Staib, A. H. Decrease of caffeine elimination in man during co-administration of 4-quinolones. J.Antimicrob.Chemother. 1987;20(5):729-734.
- Fuhr, U., Strobl, G., Manaut, F., Anders, E. M., Sorgel, F., Lopez-de-Brinas, E., Chu, D. T., Pernet, A. G., Mahr, G., Sanz, F., and . Quinolone antibacterial agents: relationship between structure and in vitro inhibition of the human cytochrome P450 isoform CYP1A2. Mol.Pharmacol. 1993;43(2):191-199.
- Kot, M. and Daniel, W. A. Effect of diethyldithiocarbamate (DDC) and ticlopidine on CYP1A2 activity and caffeine metabolism: an in vitro comparative study with human cDNA-expressed CYP1A2 and liver microsomes. Pharmacol Rep. 2009;61(6):1216-1220.
- Gasior, M., Borowicz, K., Buszewicz, G., Kleinrok, Z., and Czuczwar, S. J. Anticonvulsant activity of phenobarbital and valproate against maximal electroshock in mice during chronic treatment with caffeine and caffeine discontinuation. Epilepsia 1996;37(3):262-268.
- Jankiewicz, K., Chroscinska-Krawczyk, M., Blaszczyk, B., and Czuczwar, S. J. [Caffeine and antiepileptic drugs: experimental and clinical data]. Przegl.Lek. 2007;64(11):965-967.
- Luszczki, J. J., Zuchora, M., Sawicka, K. M., Kozinska, J., and Czuczwar, S. J. Acute exposure to caffeine decreases the anticonvulsant action of ethosuximide, but not that of clonazepam, phenobarbital and valproate against pentetrazole-induced seizures in mice. Pharmacol Rep. 2006;58(5):652-659.
- Chroscinska-Krawczyk, M., Jargiello-Baszak, M., Walek, M., Tylus, B., and Czuczwar, S. J. Caffeine and the anticonvulsant potency of antiepileptic drugs: experimental and clinical data. Pharmacol.Rep. 2011;63(1):12-18.
- Vaz, J., Kulkarni, C., David, J., and Joseph, T. Influence of caffeine on pharmacokinetic profile of sodium valproate and carbamazepine in normal human volunteers. Indian J.Exp.Biol. 1998;36(1):112-114.
- Gasior, M., Swiader, M., Przybylko, M., Borowicz, K., Turski, W. A., Kleinrok, Z., and Czuczwar, S. J. Felbamate demonstrates low propensity for interaction with methylxanthines and Ca2+ channel modulators against experimental seizures in mice. Eur.J Pharmacol 7-10-1998;352(2-3):207-214.
- Mohiuddin, M., Azam, A. T., Amran, M. S., and Hossain, M. A. In vive effects of gliclazide and metformin on the plasma concentration of caffeine in healthy rats. Pak.J Biol Sci 5-1-2009;12(9):734-737.
- Mays, D. C., Camisa, C., Cheney, P., Pacula, C. M., Nawoot, S., and Gerber, N. Methoxsalen is a potent inhibitor of the metabolism of caffeine in humans. Clin.Pharmacol.Ther. 1987;42(6):621-626.
- Wojcikowski, J. and Daniel, W. A. Perazine at therapeutic drug concentrations inhibits human cytochrome P450 isoenzyme 1A2 (CYP1A2) and caffeine metabolism--an in vitro study. Pharmacol Rep. 2009;61(5):851-858.
- Daniel, W. A., Syrek, M., Rylko, Z., and Kot, M. Effects of phenothiazine neuroleptics on the rate of caffeine demethylation and hydroxylation in the rat liver. Pol.J Pharmacol 2001;53(6):615-621.
- Norager, C. B., Jensen, M. B., Weimann, A., and Madsen, M. R. Metabolic effects of caffeine ingestion and physical work in 75-year old citizens. A randomized, double-blind, placebo-controlled, cross-over study. Clin Endocrinol (Oxf) 2006;65(2):223-228.
- Wang, X. and Yeung, J. H. Effects of the aqueous extract from Salvia miltiorrhiza Bunge on caffeine pharmacokinetics and liver microsomal CYP1A2 activity in humans and rats. J Pharm Pharmacol 2010;62(8):1077-1083.
- Gorski, J. C., Huang, S. M., Pinto, A., Hamman, M. A., Hilligoss, J. K., Zaheer, N. A., Desai, M., Miller, M., and Hall, S. D. The effect of echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivo. Clin Pharmacol Ther. 2004;75(1):89-100.
- Zheng, J., Chen, B., Jiang, B., Zeng, L., Tang, Z. R., Fan, L., and Zhou, H. H. The effects of puerarin on CYP2D6 and CYP1A2 activities in vivo. Arch Pharm Res 2010;33(2):243-246.
- Hartter, S., Nordmark, A., Rose, D. M., Bertilsson, L., Tybring, G., and Laine, K. Effects of caffeine intake on the pharmacokinetics of melatonin, a probe drug for CYP1A2 activity. Br.J.Clin.Pharmacol. 2003;56(6):679-682.
- Ursing, C., Wikner, J., Brismar, K., and Rojdmark, S. Caffeine raises the serum melatonin level in healthy subjects: an indication of melatonin metabolism by cytochrome P450(CYP)1A2. J.Endocrinol.Invest 2003;26(5):403-406.
- Liu, T. T. and Liau, J. Caffeine increases the linearity of the visual BOLD response. Neuroimage. 2-1-2010;49(3):2311-2317.
- Azcona O, Barbanoi MJ, Torrent J, Jane F. Evaluation of the central effects of alcohol and caffeine interaction. Br J Clin Pharmacol 1995;40:393-400.
- Harder S, Staib AH, Beer C, et al. 4-quinolones inhibit biotransformation of caffeine. Eur J Clin Pharmacol 1988;35:651-6.
- Zhang LL, Zhang JR, Guo K, et al. Effects of fluoroquinolones on CYP4501A and 3A in male broilers. Res Vet Sci 2011;90:99-105.
- Cesana M, Broccali G, Imbimbo BP, Crema A. Effect of single doses of rufloxacin on the disposition of theophylline and caffeine after single administration. Int J Clin Pharmacol Ther Toxicol 1991:29:133-8.
- Broughton LJ, Rogers HJ. Decreased systemic clearance of caffeine due to cimetidine. Br J Clin Pharmacol 1981;12:155-9.
- Smits P, Straatman C, Pijpers E, Thien T. Dose-dependent inhibition of the hemodynamic response to dipyridamole by caffeine. Clin Pharmacol Ther 1991;50:529-37.
- Zelenitsky SA, Norman A, Nix DE. The effects of fluconazole on the pharmacokinetics of caffeine in young and elderly subjects. J Infect Dis Pharmacother 1995;1:1-11.
- Joeres R, Richter E. Mexiletine and caffeine elimination. N Engl J Med 1987;317:117.
- Jia H, Xu A, Yuan J, et al. Experimental study on cytochrome P450 enzymes after receiving ferment powder caterpillar fungus. Zhongguo Zhong Yao Za Zhi 2009;34:2079-82.
- Arya, L. A., Myers, D. L., and Jackson, N. D. Dietary caffeine intake and the risk for detrusor instability: a case-control study. Obstet.Gynecol. 2000;96(1):85-89.
- Bryant, C. M., Dowell, C. J., and Fairbrother, G. Caffeine reduction education to improve urinary symptoms. Br.J.Nurs. 4-25-2002;11(8):560-565.
- Smits, P., Temme, L., and Thien, T. The cardiovascular interaction between caffeine and nicotine in humans. Clin Pharmacol Ther 1993;54(2):194-204.
- MacKenzie, T., Comi, R., Sluss, P., Keisari, R., Manwar, S., Kim, J., Larson, R., and Baron, J. A. Metabolic and hormonal effects of caffeine: randomized, double-blind, placebo-controlled crossover trial. Metabolism 2007;56(12):1694-1698.
- Reyes, E., Loong, C. Y., Harbinson, M., Donovan, J., Anagnostopoulos, C., and Underwood, S. R. High-dose adenosine overcomes the attenuation of myocardial perfusion reserve caused by caffeine. J Am Coll.Cardiol. 12-9-2008;52(24):2008-2016.
- Moisey, L. L., Robinson, L. E., and Graham, T. E. Consumption of caffeinated coffee and a high carbohydrate meal affects postprandial metabolism of a subsequent oral glucose tolerance test in young, healthy males. Br.J Nutr. 2010;103(6):833-841.
- Chroscinska-Krawczyk, M., Ratnaraj, N., Patsalos, P. N., and Czuczwar, S. J. Effect of caffeine on the anticonvulsant effects of oxcarbazepine, lamotrigine and tiagabine in a mouse model of generalized tonic-clonic seizures. Pharmacol Rep. 2009;61(5):819-826.
- Simmonds, M. J., Minahan, C. L., and Sabapathy, S. Caffeine improves supramaximal cycling but not the rate of anaerobic energy release. Eur.J Appl Physiol 2010;109(2):287-295.
- Rudolph, T. and Knudsen, K. A case of fatal caffeine poisoning. Acta Anaesthesiol.Scand 2010;54(4):521-523.
- Buscemi, S., Verga, S., Batsis, J. A., Donatelli, M., Tranchina, M. R., Belmonte, S., Mattina, A., Re, A., and Cerasola, G. Acute effects of coffee on endothelial function in healthy subjects. Eur.J Clin Nutr. 2010;64(5):483-489.
- Thelander, G., Jonsson, A. K., Personne, M., Forsberg, G. S., Lundqvist, K. M., and Ahlner, J. Caffeine fatalities--do sales restrictions prevent intentional intoxications? Clin Toxicol.(Phila) 2010;48(4):354-358.
- Rigato, I., Blarasin, L., and Kette, F. Severe hypokalemia in 2 young bicycle riders due to massive caffeine intake. Clin J Sport Med. 2010;20(2):128-130.
- Banko, L. T., Haq, S. A., Rainaldi, D. A., Klem, I., Siegler, J., Fogel, J., Sacchi, T. J., and Heitner, J. F. Incidence of caffeine in serum of patients undergoing dipyridamole myocardial perfusion stress test by an intensive versus routine caffeine history screening. Am.J Cardiol. 5-15-2010;105(10):1474-1479.
- Ernest, D., Chia, M., and Corallo, C. E. Profound hypokalaemia due to Nurofen Plus and Red Bull misuse. Crit Care Resusc. 2010;12(2):109-110.
- Clausen, T. Hormonal and pharmacological modification of plasma potassium homeostasis. Fundam.Clin Pharmacol 2010;24(5):595-605.
- Orozco-Gregorio, H., Mota-Rojas, D., Bonilla-Jaime, H., Trujillo-Ortega, M. E., Becerril-Herrera, M., Hernandez-Gonzalez, R., and Villanueva-Garcia, D. Effects of administration of caffeine on metabolic variables in neonatal pigs with peripartum asphyxia. Am.J Vet.Res. 2010;71(10):1214-1219.
- Alstott, R. L., Miller, A. J., and Forney, R. B. Report of a human fatality due to caffeine. J.Forensic Sci. 1973;18(2):135-137.
- Dimaio, V. J. and Garriott, J. C. Lethal caffeine poisoning in a child. Forensic Sci. 1974;3(3):275-278.
- Jeppesen, U., Loft, S., Poulsen, H. E., and Brsen, K. A fluvoxamine-caffeine interaction study. Pharmacogenetics 1996;6(3):213-222.
- Smits, P., Corstens, F. H., Aengevaeren, W. R., Wackers, F. J., and Thien, T. False-negative dipyridamole-thallium-201 myocardial imaging after caffeine infusion. J Nucl.Med. 1991;32(8):1538-1541.
- Beaudoin MS, Allen B, Mazzetti G, Sullivan PJ, Graham TE. Caffeine ingestion impairs insulin sensitivity in a dose-dependent manner in both men and women. Appl Physiol Nutr Metab. 2013;38(2):140-7. doi: 10.1139/apnm-2012-0201. Epub 2012 9.
- Bonsignore A, Sblano S, Pozzi F, Ventura F, Dell'Erba A, Palmiere C. A case of suicide by ingestion of caffeine. Forensic Sci Med Pathol. 2014 Sep;10(3):448-51. doi: 10.1007/s12024-014-9571-6. Epub 2014 27.
- Jabbar SB, Hanly MG. Fatal caffeine overdose: a case report and review of literature. Am J Forensic Med Pathol. 2013;34(4):321-4. doi: 10.1097/PAF.0000000000000058. Review.
- Poussel M, Kimmoun A, Levy B, Gambier N, Dudek F, Puskarczyk E, Poussel JF, Chenuel B. Fatal cardiac arrhythmia following voluntary caffeine overdose in an amateur body-builder athlete. Int J Cardiol. 2013 1;166(3):e41-2. doi: 10.1016/j.ijcard.2013.01.238. Epub 2013 7. No abstract available.
- Tejani FH, Thompson RC, Kristy R, Bukofzer S. Effect of caffeine on SPECT myocardial perfusion imaging during regadenoson pharmacologic stress: a prospective, randomized, multicenter study. Int J Cardiovasc Imaging. 2014 Jun;30(5):979-89. doi: 10.1007/s10554-014-0419-7. Epub 2014 17.
- Magdalan J, Zawadzki M, Skowronek R, et al. Nonfatal and fata intoxications with pure caffeine - report of three different cases. Forensic Sci Med Pathol. 2017 Sep;13(3):355-58.
- Cappelletti S, Piacentino D, Fineschi V, Frati P, Cipollini L, Aromatario M. Caffeine-related deaths: manner of deaths and categories of risk. Nutrients. 2018 May 14;10(5). pii: E611.
- Wikoff D, Welsh BT, Henderson R, et al. Systematic review of the potential adverse effects of caffeine consumption in healthy adults, pregnant women, adolescents, and children. Food Chem Toxicol 2017;109:585-648.
- Zheng KH, Zhu K, Wactawski-Wende J, et al. Caffeine intake from coffee and tea and invasive breast cancer incidence among postmenopausal women in the Women's Health Initiative. Int J Cancer 2021;149(12):2032-2044.
- Wang S, Li X, Yang Y, et al. Does coffee, tea and caffeine consumption reduce the risk of incident breast cancer? A systematic review and network meta-analysis. Public Health Nutr 2021;24(18):6377-6389.
- Alshabi AM, Alkahtani SA, Shaikh IA, Habeeb MS. Caffeine modulates pharmacokinetic and pharmacodynamic profiles of pioglitazone in diabetic rats: Impact on therapeutics. Saudi Med J 2021;42(2):151-160.
- La Monica MB, Raub B, Ziegenfuss EJ, et al. Acute effects of naturally occurring guayusa tea and Nordic lion's mane extracts on cognitive performance. Nutrients 2023;15(24):5018.
- Lee C, Dennett AM, Pinson JA, Lewis AK. Caffeine consumed prior to cardiac stress testing may affect diagnostic accuracy of nuclear medicine myocardial imaging of myocardial ischemia: A systematic review and meta-analysis. J Med Imaging Radiat Sci 2024;55(1):134-145.
- Krieger DR, Kalman DS, Feldman S, et al. The safety, pharmacokinetics, and nervous system effects of two natural sources of caffeine in healthy adult males. Clin Transl Sci 2016;9(5):246-251.
- Swanston-Flatt SK, Day C, Flatt PR, Gould BJ, Bailey CJ. Glycaemic effects of traditional European plant treatments for diabetes. Studies in normal and streptozotocin diabetic mice. Diabetes Res 1989;10(2):69-73.
- Arteaga-Crespo Y, Radice M, Bravo-Sanchez LR, García-Quintana Y, Scalvenzi L. Optimisation of ultrasound-assisted extraction of phenolic antioxidants from Ilex guayusa Loes. leaves using response surface methodology. Heliyon 2019;6(1):e03043.
- Chóez-Guaranda I, Viteri-Espinoza R, Barragán-Lucas A, Quijano-Avilés M, Manzano P. Effect of solvent-solvent partition on antioxidant activity and GC-MS profile of Ilex guayusa Loes. leaves extract and fractions. Nat Prod Res 2022;36(6):1570-1574.
- Chianese G, Golin-Pacheco SD, Taglialatela-Scafati O, et al. Bioactive triterpenoids from the caffeine-rich plants guayusa and maté. Food Res Int 2019;115:504-510.
- Pardau MD, Pereira ASP, Apostolides Z, Serem JC, Bester MJ. Antioxidant and anti-inflammatory properties of Ilex guayusa tea preparations: a comparison to Camellia sinensis teas. Food Funct 2017;8(12):4601-4610.
- Gamboa F, Muñoz CC, Numpaque G, Sequeda-Castañeda LG, Gutierrez SJ, Tellez N. Antimicrobial activity of Piper marginatum Jacq and Ilex guayusa Loes on microorganisms associated with periodontal disease. Int J Microbiol 2018;2018:4147383.
- Cadena-Carrera S, Tramontin DP, Jacques R, Scapin E, Müller JM, Hense H. Green-based methods to obtain bioactive compounds from Ilex guayusa Loes. using polar solvent. Nat Prod Res 2023;37(18):3103-3108.
- Villacís-Chiriboga J, García-Ruiz A, Baenas N, et al. Changes in phytochemical composition, bioactivity and in vitro digestibility of guayusa leaves (Ilex guayusa Loes.) in different ripening stages. J Sci Food Agric 2018;98(5):1927-1934.
- García-Ruiz A, Baenas N, Benítez-González AM, et al. Guayusa (Ilex guayusa L.) new tea: phenolic and carotenoid composition and antioxidant capacity. J Sci Food Agric 2017;97(12):3929-3936.
- Helwig NJ, Schwager LE, Berry AC, et al. Acute, dose-response effects of guayusa leaf extract on mood, cognitive and motor-cognitive performance, and blood pressure, heart rate, and ventricular repolarization. J Int Soc Sports Nutr 2024;21(1):2379424.
- Mello TC, Dias DDS, Bernardes N, et al. Ilex Guayusa Tea Improves Glycaemia and Autonomic Modulation in Female Streptozotocin-Induced Diabetic Rats. Pharmaceuticals (Basel) 2025;18(3):316.